Cargando…

The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications

Small microscopic entities known as microbes, having a population of hundreds of billions or perhaps even in trillions, reside in our gastrointestinal tract. A healthy immune system, digestion, and creation of vitamins and enzymes are all thanks to these microbes. However, new research has shown a h...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Arpit, Madkan, Suryansh, Patil, Praful
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680305/
https://www.ncbi.nlm.nih.gov/pubmed/38022117
http://dx.doi.org/10.7759/cureus.47861
_version_ 1785142360894603264
author Jain, Arpit
Madkan, Suryansh
Patil, Praful
author_facet Jain, Arpit
Madkan, Suryansh
Patil, Praful
author_sort Jain, Arpit
collection PubMed
description Small microscopic entities known as microbes, having a population of hundreds of billions or perhaps even in trillions, reside in our gastrointestinal tract. A healthy immune system, digestion, and creation of vitamins and enzymes are all thanks to these microbes. However, new research has shown a hitherto unrecognized connection between the microbiota of the intestines and the genesis of neurodegenerative diseases. Neurons in the CNS gradually deteriorate in neurodegenerative illnesses like multiple sclerosis and Parkinson's disease (PD). This deterioration impairs cognitive and physical function. Amyotrophic lateral sclerosis (ALS), PD, and Alzheimer's disease (AD) are just a few examples of neurodegenerative illnesses that pose a serious threat to world health and have few effective treatments. Recent research suggests that the gut microbiota, a diverse microbial population found in the gastrointestinal system, may substantially impact the cause and development of various diseases. The discovery of altered gut microbiota composition in people with these illnesses is one of the most critical lines of evidence connecting gut microbiota dysbiosis to neurodegenerative diseases. AD patients have a distinct characteristic of having a particular microbiota profile. In addition, an excess population of a specific microbe data profile is seen as compared to a healthy individual. Similar changes in the gut microbiota composition have been noted in people with multiple sclerosis and PD. The latest study indicates the potential that dysbiosis, a condition characterized by alteration in the intestinal microbiota's makeup and functioning, may have an effect on the onset and progression of neurodegenerative diseases, including PD and multiple sclerosis. In order to emphasize any potential underlying mechanisms and examine potential treatment repercussions, the review article's goal is to summarize current knowledge about the connection between gut microbiota and neurodegenerative disorders. The review article aims to summarize current knowledge about the connection between gut microbiota and neurodegenerative disorders, highlighting potential underlying mechanisms and examining potential treatment repercussions.
format Online
Article
Text
id pubmed-10680305
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-106803052023-10-28 The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications Jain, Arpit Madkan, Suryansh Patil, Praful Cureus Neurology Small microscopic entities known as microbes, having a population of hundreds of billions or perhaps even in trillions, reside in our gastrointestinal tract. A healthy immune system, digestion, and creation of vitamins and enzymes are all thanks to these microbes. However, new research has shown a hitherto unrecognized connection between the microbiota of the intestines and the genesis of neurodegenerative diseases. Neurons in the CNS gradually deteriorate in neurodegenerative illnesses like multiple sclerosis and Parkinson's disease (PD). This deterioration impairs cognitive and physical function. Amyotrophic lateral sclerosis (ALS), PD, and Alzheimer's disease (AD) are just a few examples of neurodegenerative illnesses that pose a serious threat to world health and have few effective treatments. Recent research suggests that the gut microbiota, a diverse microbial population found in the gastrointestinal system, may substantially impact the cause and development of various diseases. The discovery of altered gut microbiota composition in people with these illnesses is one of the most critical lines of evidence connecting gut microbiota dysbiosis to neurodegenerative diseases. AD patients have a distinct characteristic of having a particular microbiota profile. In addition, an excess population of a specific microbe data profile is seen as compared to a healthy individual. Similar changes in the gut microbiota composition have been noted in people with multiple sclerosis and PD. The latest study indicates the potential that dysbiosis, a condition characterized by alteration in the intestinal microbiota's makeup and functioning, may have an effect on the onset and progression of neurodegenerative diseases, including PD and multiple sclerosis. In order to emphasize any potential underlying mechanisms and examine potential treatment repercussions, the review article's goal is to summarize current knowledge about the connection between gut microbiota and neurodegenerative disorders. The review article aims to summarize current knowledge about the connection between gut microbiota and neurodegenerative disorders, highlighting potential underlying mechanisms and examining potential treatment repercussions. Cureus 2023-10-28 /pmc/articles/PMC10680305/ /pubmed/38022117 http://dx.doi.org/10.7759/cureus.47861 Text en Copyright © 2023, Jain et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Neurology
Jain, Arpit
Madkan, Suryansh
Patil, Praful
The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications
title The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications
title_full The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications
title_fullStr The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications
title_full_unstemmed The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications
title_short The Role of Gut Microbiota in Neurodegenerative Diseases: Current Insights and Therapeutic Implications
title_sort role of gut microbiota in neurodegenerative diseases: current insights and therapeutic implications
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680305/
https://www.ncbi.nlm.nih.gov/pubmed/38022117
http://dx.doi.org/10.7759/cureus.47861
work_keys_str_mv AT jainarpit theroleofgutmicrobiotainneurodegenerativediseasescurrentinsightsandtherapeuticimplications
AT madkansuryansh theroleofgutmicrobiotainneurodegenerativediseasescurrentinsightsandtherapeuticimplications
AT patilpraful theroleofgutmicrobiotainneurodegenerativediseasescurrentinsightsandtherapeuticimplications
AT jainarpit roleofgutmicrobiotainneurodegenerativediseasescurrentinsightsandtherapeuticimplications
AT madkansuryansh roleofgutmicrobiotainneurodegenerativediseasescurrentinsightsandtherapeuticimplications
AT patilpraful roleofgutmicrobiotainneurodegenerativediseasescurrentinsightsandtherapeuticimplications